RXO, Inc. Form 8-K Summary
Business Context and Reporting Period
RXO, Inc. filed a Form 8-K dated May 20, 2024, reporting the results of its 2024 Annual Meeting of Stockholders held on that date. The filing concerns corporate governance and shareholder voting matters, not operating or financial results.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating metrics.
Material Changes and Voting Results
| Proposal | Outcome | Key Vote |
|---|---|---|
| Election of Christine Breves as Class II director | Approved; term expires at the 2025 annual meeting | 100,047,020 for; 1,377,711 against; 21,423 abstain; 7,227,742 broker non-votes |
| Election of Adrian Kingshott as Class II director | Approved; term expires at the 2025 annual meeting | 98,075,875 for; 3,350,548 against; 19,731 abstain; 7,227,742 broker non-votes |
| Ratification of Deloitte & Touche LLP | Approved as independent registered public accounting firm for fiscal 2024 | 108,458,898 for; 68,278 against; 146,720 abstain |
| Advisory vote on executive compensation | Approved on a nonbinding basis | 92,917,681 for; 8,336,632 against; 191,841 abstain; 7,227,742 broker non-votes |
Guidance, Outlook, Risks, and Unusual Items
The filing contains no financial guidance, business outlook, management commentary, contingencies, or unusual items. It identifies Deloitte & Touche LLP as the auditor for the year ending December 31, 2024.
Investor Verification Checklist
- Verify the election and continuing terms of Christine Breves and Adrian Kingshott.
- Confirm shareholder ratification of Deloitte & Touche LLP for fiscal 2024.
- Review the definitive proxy statement filed April 9, 2024 for detailed proposal descriptions and executive compensation information.
- Use RXO’s periodic financial filings for current revenue, profitability, cash flow, leverage, liquidity, and outlook information.